Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02228304
What this trial is testing

Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Neurotech Pharmaceuticals 42
Not applicableStudy completedNCT05110209
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 331,541
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Testing effectiveness (Phase 2)UnknownNCT01521065
What this trial is testing

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationWet Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 500
Not applicableStudy completedNCT04482465
What this trial is testing

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD

Who this might be right for
Age-related Macular DegenerationVitamin D Deficiency
Universitaire Ziekenhuizen KU Leuven 50
Large-scale testing (Phase 3)Ended earlyNCT04757636
What this trial is testing

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 998
Early research (Phase 1)Study completedNCT00407719
What this trial is testing

Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationDegenerative MyopiaPathological Myopia
Johns Hopkins University 10
Not applicableUnknownNCT04907409
What this trial is testing

Home OCT Fluid Visualization Agreement Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 120
Not applicableUnknownNCT04142164
What this trial is testing

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Who this might be right for
Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Prim. Prof. Dr. Oliver Findl, MBA 40
Early research (Phase 1)Not Yet RecruitingNCT06623279
What this trial is testing

Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
HuidaGene Therapeutics Co., Ltd. 15
Post-approval studies (Phase 4)Study completedNCT01127360
What this trial is testing

LUCAS (Lucentis Compared to Avastin Study)

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 420
Testing effectiveness (Phase 2)Study completedNCT02507388
What this trial is testing

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Alcon Research 51
Not applicableStudy completedNCT00991666
What this trial is testing

Association Between Laser Interferometric Measurement of Fundus Pulsation and Pneumotonometric Measurement of Pulsatile Ocular Blood Flow in Patients With Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Medical University of Vienna 100
Not applicableUnknownNCT00627718
What this trial is testing

Assessment of Macular Edema Using HRT Technique

Who this might be right for
Age-Related Macular Degeneration
McGill University Health Centre/Research Institute of the McGill University Health Centre 50
Early research (Phase 1)Study completedNCT02848313
What this trial is testing

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Stealth BioTherapeutics Inc. 40
Not applicableStudy completedNCT01233115
What this trial is testing

LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal Vasculopathy

Who this might be right for
Age-Related Macular Degeneration
Kyungpook National University Hospital 70
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Study completedNCT05536297
What this trial is testing

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Global Development, Inc. 278
Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Next Page